Andros Pharmaceuticals’ “LTC Cream” Secures First Generic Drug Approval, Opening New Opportunities in the Local Anesthetic Market

On the 26th, Andros Pharmaceuticals announced that its independently developed topical anesthetic cream, “LTC Cream”, has received marketing approval from Taiwan’s Food and Drug Administration (TFDA). The product, indicated for pain relief on the skin surface, is the first approved generic drug in Taiwan under the TFDA’s new “Guideline for Verifying Therapeutic Equivalence of Topical Preparations”, issued last year. This milestone signifies a significant step forward for the company and the industry.